In Vitro Activity of the Active Metabolite of Prulifloxacin (AF 3013) Compared with Six Other Fluoroquinolones

[1]  T. Nishino,et al.  In Vitro Antibacterial Activity of a New Quinolone , NM 394 , 2003 .

[2]  G. Ridgway,et al.  In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates. , 1997, The Journal of antimicrobial chemotherapy.

[3]  R. Wise,et al.  In vitro activity of BAY 12-8039, a new fluoroquinolone , 1997, Antimicrobial agents and chemotherapy.

[4]  M. Ozaki,et al.  Pharmacokinetics and Safety of NM441, a New Quinolone, in Healthy Male Volunteers , 1994, Journal of clinical pharmacology.

[5]  S. Mitsuhashi,et al.  Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone , 1993, Antimicrobial Agents and Chemotherapy.

[6]  M. Nishida,et al.  In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116 , 1992, Antimicrobial Agents and Chemotherapy.

[7]  T. Nishino,et al.  In vivo evaluation of NM441, a new thiazeto-quinoline derivative , 1991, Antimicrobial Agents and Chemotherapy.

[8]  D. Hooper,et al.  Fluoroquinolone antimicrobial agents , 1989, Clinical Microbiology Reviews.

[9]  R. Wise,et al.  In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents , 1983, Antimicrobial Agents and Chemotherapy.